NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JRCT ID: jRCT1030230308

Registered date:25/08/2023

Treatment Preference in Patients with NMOSD

Basic Information

Recruitment status Recruiting
Health condition(s) or Problem(s) studiedNeuromyelitis Optica Spectrum Disorders
Date of first enrollment03/08/2023
Target sample size30
Countries of recruitment
Study typeOther
Intervention(s)

Outcome(s)

Primary Outcomecausal Relationship between Subjective Adverse Event Experience and Impact on Daily Living of Patients with NMOSD
Secondary Outcomesubjective Adverse Event Experience and Importance of Impact on Daily Living of Patients with NMOSD

Key inclusion & exclusion criteria

Age minimum>= 20age old
Age maximumNot applicable
Gender
Include criteriaSubjects who meet all of the following criteria: (1)Documented diagnosis of NMOSD (2)Anti-aquaporin-4 antibody test positive (3)Patients who are taking or have taken an oral steroid (4)Patients aged 20 years or older at the time of enrollment (5)Must have sufficient understanding to conduct the research (The patient may require assistance in reading aloud, etc. due to visual disturbance.) (6)Individuals who have consented to participate in this research (7)Patients who are living in Japan at the time of enrollment (8)Individuals who have equipment/communication environment to apply for research participation online and perform interviews or respond to questionnaires
Exclude criteriaSubjects who meet any of the following criteria: (1)Patients who have difficulty in obtaining consent or conducting this research due to a lack of Japanese ability (2)Patietnts who cannot participate in the survey

Related Information

Contact

Public contact
Name Tadashi Nagatsuka
Address 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception15F) Chuo-ku, Tokyo Tokyo Japan 1038324
Telephone +81-332816611
E-mail cma-clinicaltrial@chugai-pharm.co.jp
Affiliation Chugai Pharmaceutical Co., Ltd.
Scientific contact
Name Katsuhisa Yamashita
Address 1-1 Nihonbashi-Muromachi 2-chome, Nihonbashi Mitsui Tower (Reception15F) Chuo-ku, Tokyo Tokyo Japan 1038324
Telephone +81-332816611
E-mail cma-clinicaltrial@chugai-pharm.co.jp
Affiliation Chugai Pharmaceutical Co., Ltd.